Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Biogen to cease production of controversial Alzheimer's drug

Por: Politico Health January 31, 2024

thumbnail

Drugmaker Biogen will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment that also provoked controversy over conflicting data around its efficacy, the company said Wednesday. The FDA granted accelerated approval to the drug, which targets amyloid plaques in the brain that are thought to contribute to the disease, in 2021. That endorsement was contingent upon Biogen completing a follow-up study... + full article



Similar News

Biogen Ends Development of Alzheimer’s Drug Aduhelm

MarketWatch USA Business January 31, 2024

thumbnailThe Aduhelm commercial program had been all but dead since 2022, when the Centers for Medicare & Medicaid Services (CMS) declined to offer Medicare coverage for the drug. Biogen had been continuing of Aduhelm, however, as a condition of the Food and Drug Administration’s... + más

Biogen Ends Development of Alzheimer’s Drug Aduhelm | MarketWatch

Biogen Stock: How Biogen Makes Money In 2022 And How They Defied Gravity | Forbes


Biogen Ends Development of Alzheimer’s Drug Aduhelm

MarketWatch USA Business January 31, 2024

thumbnailThe Aduhelm commercial program had been all but dead since 2022, when the Centers for Medicare & Medicaid Services (CMS) declined to offer Medicare coverage for the drug. Biogen had been continuing of Aduhelm, however, as a condition of the Food and Drug Administration’s... + más

Biogen Ends Development of Alzheimer’s Drug Aduhelm | MarketWatch

Biogen Stock: How Biogen Makes Money In 2022 And How They Defied Gravity | Forbes


Did Martha Washington really name a cat after Alexander Hamilton?

The Boston Globe USA Life February 22, 2023

thumbnailTRENTON, N.J. (AP) — In the song ''A Winter's Ball'' in the smash Broadway hit ''Hamilton,'' Aaron Burr's character sings of Alexander Hamilton's delight for women, including the tale that Martha Washington named her feral... + más

Doorbell cam catches touching reunion between lost cat and family | Newsweek

Hamilton Celebrates Hollywood And 130 Years Of Watchmaking | Forbes


'Frustration' fuels Denver Broncos' sideline blowup in loss

ABC News USA Sports November 28, 2022

thumbnailCHARLOTTE, N.C. -- In a season in which the only thing the can consistently do, it seems, is raise their own frustration level with one loss after another, a brief sideline blowup between defensive tackle and quarterback was caught on camera Sunday.It came early in the fourth... + más

'Frustration' fuels Broncos' sideline blowup in loss | ESPN

Sources: Denver Broncos RB Javonte Williams out for season with torn ACL, LCL | ABC News


'Frustration' fuels Broncos' sideline blowup in loss

ESPN USA Sports November 28, 2022

thumbnailCHARLOTTE, N.C. -- In a season in which the only thing the can consistently do, it seems, is raise their own frustration level with one loss after another, a brief sideline blowup between defensive tackle and quarterback was caught on camera Sunday.It came early in the fourth... + más

'Frustration' fuels Denver Broncos' sideline blowup in loss | ABC News

Sources: Denver Broncos RB Javonte Williams out for season with torn ACL, LCL | ABC News


Healthy Mayfield 'rolling with the punches' as QB2

ESPN USA Sports October 28, 2022

thumbnailCHARLOTTE, N.C. -- , despite being healthy enough to play on Sunday when the face the , is accepting his role as the backup to journeyman quarterback .This will be the first time since the first three games of his rookie season with the that the top pick of the 2018 draft... + más

Panthers' Baker Mayfield 'rolling with the punches' as QB2 | ABC News

Mayfield adapting to backup role, doesn't want to be traded | Associated Press


Biogen Stock: How Biogen Makes Money In 2022 And How They Defied Gravity

Forbes USA Business October 15, 2022

thumbnailGetty Images Key Takeaways You may have heard the overwhelmingly positive news for Biogen lately—this stock has been a rare winner during a time of extreme volatility in the stock market due to consistent rate hikes. Biogen Inc. (BIBB) is one of the older global biotech... + más

Biogen to pay $900M to settle allegations of improper physician kickbacks | Fox Business

Biogen to pay $900 million to settle allegations it paid doctors kickbacks to prescribe multiple sclerosis drugs | CNBC



About iurex | Privacy Policy | Disclaimer |